m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00267)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
GLI1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | HUVEC cell line | Homo sapiens |
Treatment: shMETTL3 HUVEC cells
Control: shScramble HUVEC cells
|
GSE157544 | |
Regulation |
|
logFC: 7.30E-01 p-value: 2.91E-03 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between GLI1 and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 7.23E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 silence decreased the m6A modification and expression of Zinc finger protein GLI1 (GLI1), an important component of hedgehog pathway, which led to cell apoptosis.the m6A methyltransferase METTL3 promotes the growth and motility of prostate cancer cells by regulating hedgehog pathway. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Prostate cancer | ICD-11: 2C82 | ||
Pathway Response | Hedgehog signaling pathway | hsa04340 | ||
Cell Process | Cell proliferation | |||
Cell survival | ||||
Cell colony formation | ||||
Cell invasion | ||||
In-vitro Model | LNCaP C4-2 | Prostate carcinoma | Homo sapiens | CVCL_4782 |
LNCaP C4-2B | Prostate carcinoma | Homo sapiens | CVCL_4784 | |
DU145 | Prostate carcinoma | Homo sapiens | CVCL_0105 | |
LNCaP | Prostate carcinoma | Homo sapiens | CVCL_0395 | |
PC-3 | Prostate carcinoma | Homo sapiens | CVCL_0035 | |
In-vivo Model | Equal number of PC-3 cells was injected subcutaneously into right flank. | |||
Prostate cancer [ICD-11: 2C82]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 silence decreased the m6A modification and expression of Zinc finger protein GLI1 (GLI1), an important component of hedgehog pathway, which led to cell apoptosis.the m6A methyltransferase METTL3 promotes the growth and motility of prostate cancer cells by regulating hedgehog pathway. | |||
Responsed Disease | Prostate cancer [ICD-11: 2C82] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Hedgehog signaling pathway | hsa04340 | ||
Cell Process | Cell proliferation | |||
Cell survival | ||||
Cell colony formation | ||||
Cell invasion | ||||
In-vitro Model | LNCaP C4-2 | Prostate carcinoma | Homo sapiens | CVCL_4782 |
LNCaP C4-2B | Prostate carcinoma | Homo sapiens | CVCL_4784 | |
DU145 | Prostate carcinoma | Homo sapiens | CVCL_0105 | |
LNCaP | Prostate carcinoma | Homo sapiens | CVCL_0395 | |
PC-3 | Prostate carcinoma | Homo sapiens | CVCL_0035 | |
In-vivo Model | Equal number of PC-3 cells was injected subcutaneously into right flank. | |||